Renfei Wu, Ph.D.

 Postdoc (Heeschen Lab)  

 Email: wu_renfei@163.com

 Office: Room 401, East 5 building

 Wu graduated from College of Life Sciences at Wuhan University, and obtained M.Phil. from Division of Life Sciences at Hong Kong University of Science and Technology, Ph.D. from Faculty of Health Sciences at University of Macau. His research interests focus on unraveling molecular mechanisms of cancer metastasis and drug resistance. Wu joined Heeschen lab in August 2021 and is exploring driving factors for pancreatic cancer metastasis by combining single cell sequencing and spatial transcriptomics techniques.

Publications:

1. Renfei Wu, Koukou Li, Mingheng Yuan, Kathy Qian Luo* (2021). Nerve growth factor receptor increases the metastatic potential of triple-negative breast cancer cells. Oncogene. 40(12):2165-2181. (IF=9.9)

2. Renfei Wu, Kathy Qian Luo* (2021). Developing effective siRNAs to reduce the expression of key viral genes of COVID-19. International Journal of Biological Sciences. 17(6):1521-1529. (IF=6.6)

3. Koukou Li, Renfei Wu, Muya Zhou, Haibo Tong, Kathy Qian Luo* (2021). DSC2 and PKP1 increase the cluster formation, survival and metastasis of circulating tumor cells. Science Advances. 7(40):eabg7265. (IF=14.1)

4. Man Luo, Afu Fu, Renfei Wu, Na Wei, Kai Song, Sierin Lim, Kathy Qian Luo*. High expression of G6PD increases doxorubicin resistance in triple negative breast cancer cells by maintaining GSH level. International Journal of Biological Sciences. (In press, Co-first author, IF=6.6)